Published on 01/07/2026 at 03:08 am EST
(MT Newswires) -- Chinese shares again rose on Wednesday, albeit at a slower rate, as the central bank pledged to maintain ample liquidity
The Shanghai Composite Index, the main gauge of Chinese stocks, rose 2.11 points to 4,085.677, touching its highest level since July 2015. The Shenzhen Component Index climbed.8,01% points to 4,030.56.
"Clients see limited downside risk ?in January, ?with capital returning to popular themes and a tactical upside window before the holiday lull," The Malay Mail cited UBS analysts as saying.
UBS added that the rebound in Chinese equities since December 2025 boosted market confidence, with investors expected to remain active until this year's Spring Festival.
In company news, Sichuan Biokin Pharmaceutical's (SHA:688506) iza-bren was included in the priority review drug list of the Chinese National Medical Products Administration's Center for Drug Evaluation. Shares of the company closed 3 % lower Wednesday.

Sumber : MT Newswires